Clinical Drug Experience Knowledgebase

anastrozole (arimidex) (1 trial)

cyclophosphamide (cytoxan) (7 trials)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (4 trials)

epirubicin (ellence) (3 trials)

estradiol (progynon depot) (1 trial)

exemestane (aromasin) (5 trials)

fluorouracil (efudex) (2 trials)

fulvestrant (faslodex) (2 trials)

goserelin (zoladex) (1 trial)

letrozole (femara) (5 trials)

mesna (mesnex) (1 trial)

naltrexone (revia) (4 trials)

norethindrone (1 trial)

paclitaxel (taxol) (4 trials)

palbociclib (ibrance) (3 trials)

peripheral blood hematopoietic cell (1 trial)

risedronate (actonel) (1 trial)

sargramostim (leukine) (1 trial)

sitagliptin (januvia) (1 trial)

tamoxifen (nolvadex) (9 trials)

temsirolimus (torisel) (1 trial)

toremifene (fareston) (1 trial)

trastuzumab (herceptin) (2 trials)

triptorelin (Trelstar) (5 trials)

vinorelbine (navelbine) (2 trials)

capecitabine (xeloda) (1 trial)

degarelix acetate (firmagon) (1 trial)

pembrolizumab (keytruda) (1 trial)

pertuzumab (perjeta) (1 trial)